Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Larimar Therapeutics, Inc. | 225,622 | reported | 26 Jan 2026 | tx 15+1,240,597 |
| ORASURE TECHNOLOGIES INC | 111,823 | reported | 12 Aug 2022 | tx 40+348,780−156,957 |
| Recro Pharma, Inc. | 67,500 | reported | 18 Jan 2019 | tx 21+441,828−28,391 |
| KENSEY NASH CORP | 0 | reported | 22 Jun 2012 | tx 12+76,600−76,600 |
1 purchase reported after at least 12 months of silence — most recent on 12 Aug 2022.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jan 2026 | GRANT_AWARD | Larimar Therapeutics, Inc. | 37,604 | 0.00 USD | |
| 26 Jan 2026 | GRANT_AWARD | Larimar Therapeutics, Inc. | 225,622 | 0.00 USD | deriv |
| 22 Jan 2025 | GRANT_AWARD | Larimar Therapeutics, Inc. | 34,185 | 0.00 USD | |
| 22 Jan 2025 | GRANT_AWARD | Larimar Therapeutics, Inc. | 205,111 | 0.00 USD | deriv |
| 17 Jan 2024 | GRANT_AWARD | Larimar Therapeutics, Inc. | 31,250 | 0.00 USD | |
| 17 Jan 2024 | GRANT_AWARD | Larimar Therapeutics, Inc. | 187,500 | 0.00 USD | deriv |
| 17 May 2023 | PURCHASE | Larimar Therapeutics, Inc. | 5,000 | 3.73 USD | |
| 31 Jan 2023 | GRANT_AWARD | Larimar Therapeutics, Inc. | 76,000 | 0.00 USD | |
| 31 Jan 2023 | GRANT_AWARD | Larimar Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |
| 16 Sept 2022 | PURCHASE | Larimar Therapeutics, Inc. | 31,746 | 3.15 USD | |
| 12 Aug 2022 | PURCHASE | ORASURE TECHNOLOGIES INC | 12,000 | 4.49 USD | first after silence |
| 16 May 2022 | TAX_WITHHOLDING | ORASURE TECHNOLOGIES INC | 3,399 | 5.25 USD | |
| 16 May 2022 | GRANT_AWARD | ORASURE TECHNOLOGIES INC | 24,762 | 5.25 USD | |
| 10 May 2022 | GRANT_AWARD | Larimar Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 18 Jan 2022 | GRANT_AWARD | Larimar Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
| 18 May 2021 | GRANT_AWARD | ORASURE TECHNOLOGIES INC | 13,559 | 9.59 USD | |
| 17 May 2021 | TAX_WITHHOLDING | ORASURE TECHNOLOGIES INC | 2,041 | 9.50 USD | |
| 19 Jan 2021 | GRANT_AWARD | Larimar Therapeutics, Inc. | 42,000 | 0.00 USD | deriv |
| 29 Sept 2020 | GRANT_AWARD | Larimar Therapeutics, Inc. | 84,100 | 0.00 USD | deriv |
| 28 May 2020 | GRANT_AWARD | Larimar Therapeutics, Inc. | 60,479 | 0.00 USD | deriv |
| 15 May 2020 | TAX_WITHHOLDING | ORASURE TECHNOLOGIES INC | 3,843 | 16.04 USD | |
| 18 May 2020 | GRANT_AWARD | ORASURE TECHNOLOGIES INC | 8,143 | 15.97 USD | |
| 21 May 2019 | GRANT_AWARD | ORASURE TECHNOLOGIES INC | 15,330 | 8.48 USD | |
| 18 Jan 2019 | TAX_WITHHOLDING | Recro Pharma, Inc. | 1,782 | 7.99 USD | |
| 18 Jan 2019 | GRANT_AWARD | Recro Pharma, Inc. | 12,672 | 0.00 USD |